초기 1상모집 중단 (진행 중)

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

연구 개요

This study adds irinotecan, temozolomide and bevacizumab to the chemotherapy regimen currently used to treat Desmoplastic small round cell tumor (DSRCT). The investigators are doing this study to find out what effects, good and/or bad, the combination of irinotecan, temozolomide and bevacizumab has on the patient and the DSRCT cancer.

스폰서: 협력: 로슈
적응증: Sarcoma, Desmoplastic Small Round Cell Tumor (DSRCT)
중재: irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator
목표 등록: 15명
시작일: 2010-08-01
완료(예정): 2026-08-01
등록번호: NCT01189643 · ClinicalTrials.gov ↗

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.